{"id":91387,"date":"2025-12-05T01:43:38","date_gmt":"2025-12-05T00:43:38","guid":{"rendered":"https:\/\/www.veeva.com\/eu\/?post_type=customer-stories&#038;p=91387"},"modified":"2026-08-20T17:55:47","modified_gmt":"2026-08-20T15:55:47","slug":"dermavant-sciences-shaves-weeks-off-its-nda-timeline","status":"publish","type":"customer-stories","link":"https:\/\/www.veeva.com\/eu\/customer-stories\/dermavant-sciences-shaves-weeks-off-its-nda-timeline\/","title":{"rendered":"Dermavant"},"content":{"rendered":"<p>\nShortly after Jason Maze started at Dermavant Sciences<br \/>\nas the director of global regulatory systems and information<br \/>\nmanagement, he began implementing a new publishing platform<br \/>\nfrom the ground up in an almost totally green-field environment.\n<\/p>\n<p>\nHaving supported the publishing and submissions functions at a<br \/>\nnumber of similar organizations, Maze believed that a paradigm<br \/>\nshift was long overdue. \u201cPublishing is a very important piece of<br \/>\nthe puzzle,\u201d he explains. \u201cBut I\u2019ve always felt like it was done in the<br \/>\nwrong way. Publishing needs to be mainlined and integrated into<br \/>\nthe day-to-day process of application development rather than<br \/>\nbeing treated as a separate task at the end of the process.\u201d\n<\/p>\n<h2>Bringing publishing into the mainstream<\/h2>\n<p>\nAt Dermavant, Maze put his theory into action. With no formal information management system in place, the<br \/>\nimmuno-dermatology company collected regulatory documents and shared files through Microsoft SharePoint.<br \/>\nBeyond that, they managed an inefficient process for submission publishing: Content writers first collaborated<br \/>\ninternally, then handed documents over to external publishing contractors, and brought the final dossier back in<br \/>\nhouse for quality check and review. From there, they\u2019d often send files back to the contractors for corrections\u2014<br \/>\nall during a time when Dermavant was racing to be first to market with a new drug for treating plaque psoriasis.\n<\/p>\n<p>\nMaze realized that with the right technology partner, he could significantly streamline the company\u2019s publishing<br \/>\nprocess. \u201cWe already work very closely with our medical and scientific writing teams to maintain document<br \/>\nquality from as early on in the process as possible,\u201d he says. \u201cWe knew that if we had an easy-to-use system that<br \/>\ncould extend this sort of collaboration, those teams would embrace it.\u201d\n<\/p>\n<h2>Building the perfect platform<\/h2>\n<p>\nMaze didn\u2019t need to look far for a solution. Dermavant previously implemented the <a href=\"https:\/\/www.veeva.com\/eu\/products\/veeva-rim\/\">Veeva RIM Suite<\/a> to unify<br \/>\nregulatory processes, but they weren\u2019t maximizing its usage when he joined. Already experienced with Vault RIM<br \/>\nfrom his work at other companies, Maze immediately began to train the Dermavant teams on the suite\u2014<br \/>\nspecifically <a href=\"https:\/\/www.veeva.com\/eu\/products\/veeva-submissions\/\">Veeva Submissions<\/a>, <a href=\"https:\/\/www.veeva.com\/eu\/products\/veeva-submissions-archive\/\">Veeva Submissions Archive<\/a>, and <a href=\"https:\/\/www.veeva.com\/eu\/products\/veeva-submissions-publishing\/\">Veeva Submissions Publishing<\/a>.\n<\/p>\n<p>\nLuckily for Maze and team, getting users onboarded was a relatively easy process. \u201cThere\u2019s so much industry<br \/>\nexperience built into Veeva RIM that you can stand it up very quickly and have an out-of-the-box version ready for<br \/>\nyour user community,\u201d he explains. \u201cFor that reason, our approach was to set up as close to a stripped down<br \/>\nversion of the platform as possible and then build it out from there to reflect our own processes. We wanted the<br \/>\nplatform to be compliant but not complex.\u201d\n<\/p>\n<p>\n<vid class=\"mt-0\"><br \/>\n<script src=\"https:\/\/fast.wistia.com\/embed\/medias\/dnhbvbbbwz.jsonp\" async><\/script><\/p>\n<div class=\"wistia_responsive_padding\" style=\"padding:56.25% 0 0 0;position:relative;\">\n<div class=\"wistia_responsive_wrapper\" style=\"height:100%;left:0;position:absolute;top:0;width:100%;\">\n<div class=\"wistia_embed wistia_async_dnhbvbbbwz videoFoam=true\" style=\"height:100%;position:relative;width:100%\">\n<\/div>\n<\/div>\n<\/div>\n<p><\/vid>\n<\/p>\n<h2>Piloting for success<\/h2>\n<p>\nWith that in mind, Maze assembled a pilot project with members of the content writing teams so that he could<br \/>\nget a sense of how they were using the tool, what they needed from it, and what was missing. He quickly<br \/>\nidentified several process inefficiencies: Writers spent time redoing\u2014or worse, undoing\u2014existing work, so Maze<br \/>\nimmediately introduced gated workflows. As a result, says Maze, \u201cour publishing process became much more<br \/>\nefficient. The quality of work went up and the rework went down to almost nothing.\u201d\n<\/p>\n<p>\nAs both the content team and the development team became more familiar with working in the system,<br \/>\nVault RIM evolved into the single source of truth for documents and data. It was simple for users to learn and<br \/>\ndevelopers appreciated that it was easy to customize.\n<\/p>\n<p>\nWhile Maze and team originally planned to initiate content management in Vault RIM in parallel with their external<br \/>\npublishing processes, they quickly came to realize that the whole operation could take place in-house with Veeva.\n<\/p>\n<h2>NDA-ready<\/h2>\n<p>\nAfter the success of the pilot project and the team\u2019s first small submission (a process that took about six<br \/>\nweeks), Dermavant made the decision to go all in on Veeva Submissions Publishing\u2014which meant that they\u2019d<br \/>\npublish and submit their upcoming NDA exclusively through Veeva RIM.\n<\/p>\n<blockquote><p>&#8220;There\u2019s so much industry experience built into Vault RIM that you can stand it up very quickly<br \/>\nand have an out-of-the-box version ready for your user community.&#8221;<br \/>\n<span>Jason Maze, director of global regulatory systems and information management, Dermavant Sciences<\/span>\n<\/p><\/blockquote>\n<p>\nKnowing that they had to move fast to meet the NDA timeline, Maze wanted to get as close to real-time publishing<br \/>\nas possible. This included moving the traditional quality check and document formatting process farther<br \/>\nupstream into the author channel. After building out content templates so that people could see how a document<br \/>\nshould look and feel right from the start, users went to Maze\u2019s team any time a document seemed to go off track.\n<\/p>\n<p>\nAs a result, they were able to spot and fix problems much earlier in the process than they were able to in the<br \/>\npast. The fact that writers were also able to hyperlink to other documents in Vault RIM also helped bring the<br \/>\norganization closer to Maze\u2019s goal of real-time publishing.\n<\/p>\n<h2>Upping speed, efficiency, and user experience<\/h2>\n<p>\n\u201cWe had a very distinct goal at Dermavant of changing the way we published documents,\u201d says Maze.<br \/>\n\u201cThe proof that we met our goal is in the NDA\u2014the speed with which we got it done and the quality of that<br \/>\ndossier. We didn\u2019t have a Plan B. It was all about bringing in Veeva RIM, getting user adoption, achieving<br \/>\nprocess improvements, and making the NDA happen at breakneck speed.\u201d\n<\/p>\n<p>\nIn the end, the Dermavant team shaved a month off the NDA timeline and as much as six weeks off their<br \/>\ninternal deadline.\n<\/p>\n<p>\nWhile speed and efficiency were certainly important, Maze was equally concerned about creating a better<br \/>\nworkflow and experience for his publishing team. He\u2019s happy to report success in that area as well.\n<\/p>\n<p>\nSays Maze, \u201cBecause we have such a small user community, we can really sense their mood every day. We know<br \/>\nwhen their frustration level is high, and when they\u2019re feeling like everything is broken. Now that we\u2019re using Vault<br \/>\nRIM, we just don\u2019t get that feeling from them anymore. Everything is stable and sound.\u201d\n<\/p>\n<p>\nAs a result, document quality is up and the pressure is off the users. \u201cEveryone can relax,\u201d says Maze. \u201cThey no<br \/>\nlonger feel like they have to track every aspect of the process themselves. With Veeva RIM, there\u2019s a formal<br \/>\nmechanism for everything, and everybody knows that the document is a work-in-progress until it\u2019s reached the<br \/>\nfinal stages in the system.\u201d\n<\/p>\n<h2>The road ahead<\/h2>\n<p>\nNow that Dermavant employees are comfortable with Vault RIM, Maze is looking forward to taking advantage<br \/>\nof the integrations among the rest of the solutions in the Vault RIM Suite. This includes expanding the way<br \/>\nthey\u2019re using Vault RIM to make it more of a planning tool, building more robust templates, and increasing<br \/>\ntraining options.\n<\/p>\n<p>\n\u201cWe want to make it the center of our regulatory universe, not just the machine that pushes the content through<br \/>\nand makes submissions,\u201d says Maze. \u201cWith the help of the Veeva team, we hope to find the best way to build it<br \/>\nout and achieve this transformation.\u201d\n<\/p>\n<hr>\n<p>\nDue to his success in streamlining Dermavant\u2019s publishing process, Veeva recognized Jason Maze as a<br \/>\nRegulatory Hero at its 2021 R&#038;D and Quality Summit. Watch Jason\u2019s Summit session at <a href=\"https:\/\/veevaconnect.com\/articles\/2021_RDQ_Reg_5\">veevaconnect.com<\/a>.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Dermavant Sciences improves the speed, efficiency, and user experience of its submissions planning and publishing process with the Veeva RIM Suite.<\/p>\n","protected":false},"featured_media":62517,"parent":0,"template":"","product-link-list":[],"class_list":["post-91387","customer-stories","type-customer-stories","status-publish","has-post-thumbnail","hentry"],"aioseo_notices":[],"aioseo_head":"\n\t\t<!-- All in One SEO Pro 5.0.1 - aioseo.com -->\n\t<meta name=\"description\" content=\"Dermavant Sciences improves the speed, efficiency, and user experience of its submissions planning and publishing process with the Veeva RIM Suite.\" \/>\n\t<meta name=\"robots\" content=\"max-image-preview:large\" \/>\n\t<meta name=\"generator\" content=\"All in One SEO Pro (AIOSEO) 5.0.1\" \/>\n\t\t<meta property=\"og:locale\" content=\"en_US\" \/>\n\t\t<meta property=\"og:site_name\" content=\"Veeva Systems Europe\" \/>\n\t\t<meta property=\"og:type\" content=\"article\" \/>\n\t\t<meta property=\"og:title\" content=\"Dermavant Sciences Shaves Weeks Off Its NDA Timeline | Veeva Systems Europe\" \/>\n\t\t<meta property=\"og:description\" content=\"Dermavant Sciences improves the speed, efficiency, and user experience of its submissions planning and publishing process with the Veeva RIM Suite.\" \/>\n\t\t<meta property=\"og:image\" content=\"https:\/\/www.veeva.com\/wp-content\/uploads\/2021\/11\/Dermavant-Case-Study_1200x630.png\" \/>\n\t\t<meta property=\"og:image:secure_url\" content=\"https:\/\/www.veeva.com\/wp-content\/uploads\/2021\/11\/Dermavant-Case-Study_1200x630.png\" \/>\n\t\t<meta property=\"article:published_time\" content=\"2025-12-05T00:43:38+00:00\" \/>\n\t\t<meta property=\"article:modified_time\" content=\"2026-08-20T15:55:47+00:00\" \/>\n\t\t<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n\t\t<meta name=\"twitter:title\" content=\"Dermavant Sciences Shaves Weeks Off Its NDA Timeline | Veeva Systems Europe\" \/>\n\t\t<meta name=\"twitter:description\" content=\"Dermavant Sciences improves the speed, efficiency, and user experience of its submissions planning and publishing process with the Veeva RIM Suite.\" \/>\n\t\t<meta name=\"twitter:image\" content=\"https:\/\/www.veeva.com\/wp-content\/uploads\/2021\/11\/Dermavant-Case-Study_1200x630.png\" \/>\n\t\t<script type=\"application\/ld+json\" class=\"aioseo-schema\">\n\t\t\t{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.veeva.com\\\/eu\\\/customer-stories\\\/dermavant-sciences-shaves-weeks-off-its-nda-timeline\\\/#breadcrumblist\",\"itemListElement\":[{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/www.veeva.com\\\/eu#listItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.veeva.com\\\/eu\",\"nextItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/www.veeva.com\\\/eu\\\/customer-stories\\\/#listItem\",\"name\":\"C. Stories\"}},{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/www.veeva.com\\\/eu\\\/customer-stories\\\/#listItem\",\"position\":2,\"name\":\"C. Stories\",\"item\":\"https:\\\/\\\/www.veeva.com\\\/eu\\\/customer-stories\\\/\",\"nextItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/www.veeva.com\\\/eu\\\/customer-stories\\\/dermavant-sciences-shaves-weeks-off-its-nda-timeline\\\/#listItem\",\"name\":\"Dermavant\"},\"previousItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/www.veeva.com\\\/eu#listItem\",\"name\":\"Home\"}},{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/www.veeva.com\\\/eu\\\/customer-stories\\\/dermavant-sciences-shaves-weeks-off-its-nda-timeline\\\/#listItem\",\"position\":3,\"name\":\"Dermavant\",\"previousItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/www.veeva.com\\\/eu\\\/customer-stories\\\/#listItem\",\"name\":\"C. Stories\"}}]},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/www.veeva.com\\\/eu\\\/#organization\",\"name\":\"Veeva Systems Europe\",\"description\":\"EU Site\",\"url\":\"https:\\\/\\\/www.veeva.com\\\/eu\\\/\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.veeva.com\\\/eu\\\/customer-stories\\\/dermavant-sciences-shaves-weeks-off-its-nda-timeline\\\/#webpage\",\"url\":\"https:\\\/\\\/www.veeva.com\\\/eu\\\/customer-stories\\\/dermavant-sciences-shaves-weeks-off-its-nda-timeline\\\/\",\"name\":\"Dermavant Sciences Shaves Weeks Off Its NDA Timeline | Veeva Systems Europe\",\"description\":\"Dermavant Sciences improves the speed, efficiency, and user experience of its submissions planning and publishing process with the Veeva RIM Suite.\",\"inLanguage\":\"en-US\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.veeva.com\\\/eu\\\/#website\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.veeva.com\\\/eu\\\/customer-stories\\\/dermavant-sciences-shaves-weeks-off-its-nda-timeline\\\/#breadcrumblist\"},\"image\":{\"@type\":\"ImageObject\",\"url\":\"https:\\\/\\\/www.veeva.com\\\/eu\\\/wp-content\\\/uploads\\\/2022\\\/02\\\/customer-story-logo-dermavant.png\",\"@id\":\"https:\\\/\\\/www.veeva.com\\\/eu\\\/customer-stories\\\/dermavant-sciences-shaves-weeks-off-its-nda-timeline\\\/#mainImage\",\"width\":500,\"height\":200},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.veeva.com\\\/eu\\\/customer-stories\\\/dermavant-sciences-shaves-weeks-off-its-nda-timeline\\\/#mainImage\"},\"datePublished\":\"2025-12-05T01:43:38+01:00\",\"dateModified\":\"2026-08-20T17:55:47+02:00\"},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.veeva.com\\\/eu\\\/#website\",\"url\":\"https:\\\/\\\/www.veeva.com\\\/eu\\\/\",\"name\":\"Veeva Systems Europe\",\"description\":\"EU Site\",\"inLanguage\":\"en-US\",\"publisher\":{\"@id\":\"https:\\\/\\\/www.veeva.com\\\/eu\\\/#organization\"}}]}\n\t\t<\/script>\n\t\t<!-- All in One SEO Pro -->\r\n\t\t<title>Dermavant Sciences Shaves Weeks Off Its NDA Timeline | Veeva Systems Europe<\/title>\n\n","aioseo_head_json":{"title":"Dermavant Sciences Shaves Weeks Off Its NDA Timeline | Veeva Systems Europe","description":"Dermavant Sciences improves the speed, efficiency, and user experience of its submissions planning and publishing process with the Veeva RIM Suite.","canonical_url":"","robots":"max-image-preview:large","keywords":"","webmasterTools":{"miscellaneous":""},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"BreadcrumbList","@id":"https:\/\/www.veeva.com\/eu\/customer-stories\/dermavant-sciences-shaves-weeks-off-its-nda-timeline\/#breadcrumblist","itemListElement":[{"@type":"ListItem","@id":"https:\/\/www.veeva.com\/eu#listItem","position":1,"name":"Home","item":"https:\/\/www.veeva.com\/eu","nextItem":{"@type":"ListItem","@id":"https:\/\/www.veeva.com\/eu\/customer-stories\/#listItem","name":"C. Stories"}},{"@type":"ListItem","@id":"https:\/\/www.veeva.com\/eu\/customer-stories\/#listItem","position":2,"name":"C. Stories","item":"https:\/\/www.veeva.com\/eu\/customer-stories\/","nextItem":{"@type":"ListItem","@id":"https:\/\/www.veeva.com\/eu\/customer-stories\/dermavant-sciences-shaves-weeks-off-its-nda-timeline\/#listItem","name":"Dermavant"},"previousItem":{"@type":"ListItem","@id":"https:\/\/www.veeva.com\/eu#listItem","name":"Home"}},{"@type":"ListItem","@id":"https:\/\/www.veeva.com\/eu\/customer-stories\/dermavant-sciences-shaves-weeks-off-its-nda-timeline\/#listItem","position":3,"name":"Dermavant","previousItem":{"@type":"ListItem","@id":"https:\/\/www.veeva.com\/eu\/customer-stories\/#listItem","name":"C. Stories"}}]},{"@type":"Organization","@id":"https:\/\/www.veeva.com\/eu\/#organization","name":"Veeva Systems Europe","description":"EU Site","url":"https:\/\/www.veeva.com\/eu\/"},{"@type":"WebPage","@id":"https:\/\/www.veeva.com\/eu\/customer-stories\/dermavant-sciences-shaves-weeks-off-its-nda-timeline\/#webpage","url":"https:\/\/www.veeva.com\/eu\/customer-stories\/dermavant-sciences-shaves-weeks-off-its-nda-timeline\/","name":"Dermavant Sciences Shaves Weeks Off Its NDA Timeline | Veeva Systems Europe","description":"Dermavant Sciences improves the speed, efficiency, and user experience of its submissions planning and publishing process with the Veeva RIM Suite.","inLanguage":"en-US","isPartOf":{"@id":"https:\/\/www.veeva.com\/eu\/#website"},"breadcrumb":{"@id":"https:\/\/www.veeva.com\/eu\/customer-stories\/dermavant-sciences-shaves-weeks-off-its-nda-timeline\/#breadcrumblist"},"image":{"@type":"ImageObject","url":"https:\/\/www.veeva.com\/eu\/wp-content\/uploads\/2022\/02\/customer-story-logo-dermavant.png","@id":"https:\/\/www.veeva.com\/eu\/customer-stories\/dermavant-sciences-shaves-weeks-off-its-nda-timeline\/#mainImage","width":500,"height":200},"primaryImageOfPage":{"@id":"https:\/\/www.veeva.com\/eu\/customer-stories\/dermavant-sciences-shaves-weeks-off-its-nda-timeline\/#mainImage"},"datePublished":"2025-12-05T01:43:38+01:00","dateModified":"2026-08-20T17:55:47+02:00"},{"@type":"WebSite","@id":"https:\/\/www.veeva.com\/eu\/#website","url":"https:\/\/www.veeva.com\/eu\/","name":"Veeva Systems Europe","description":"EU Site","inLanguage":"en-US","publisher":{"@id":"https:\/\/www.veeva.com\/eu\/#organization"}}]},"og:locale":"en_US","og:site_name":"Veeva Systems Europe","og:type":"article","og:title":"Dermavant Sciences Shaves Weeks Off Its NDA Timeline | Veeva Systems Europe","og:description":"Dermavant Sciences improves the speed, efficiency, and user experience of its submissions planning and publishing process with the Veeva RIM Suite.","og:image":"https:\/\/www.veeva.com\/wp-content\/uploads\/2021\/11\/Dermavant-Case-Study_1200x630.png","og:image:secure_url":"https:\/\/www.veeva.com\/wp-content\/uploads\/2021\/11\/Dermavant-Case-Study_1200x630.png","article:published_time":"2025-12-05T00:43:38+00:00","article:modified_time":"2026-08-20T15:55:47+00:00","twitter:card":"summary_large_image","twitter:title":"Dermavant Sciences Shaves Weeks Off Its NDA Timeline | Veeva Systems Europe","twitter:description":"Dermavant Sciences improves the speed, efficiency, and user experience of its submissions planning and publishing process with the Veeva RIM Suite.","twitter:image":"https:\/\/www.veeva.com\/wp-content\/uploads\/2021\/11\/Dermavant-Case-Study_1200x630.png"},"aioseo_meta_data":{"post_id":"91387","title":"Dermavant Sciences Shaves Weeks Off Its NDA Timeline #separator_sa #site_title","description":null,"keywords":null,"keyphrases":{"focus":{"keyphrase":"","score":0,"analysis":{"keyphraseInTitle":{"score":0,"maxScore":9,"error":1}}},"additional":[]},"primary_term":null,"canonical_url":null,"og_title":"Dermavant Sciences Shaves Weeks Off Its NDA Timeline #separator_sa #site_title","og_description":"#post_excerpt","og_object_type":"default","og_image_type":"custom_image","og_image_url":"https:\/\/www.veeva.com\/wp-content\/uploads\/2021\/11\/Dermavant-Case-Study_1200x630.png","og_image_width":"0","og_image_height":"0","og_image_custom_url":"https:\/\/www.veeva.com\/wp-content\/uploads\/2021\/11\/Dermavant-Case-Study_1200x630.png","og_image_custom_fields":null,"og_video":"","og_custom_url":null,"og_article_section":null,"og_article_tags":null,"twitter_use_og":true,"twitter_card":"default","twitter_image_type":"default","twitter_image_url":null,"twitter_image_custom_url":null,"twitter_image_custom_fields":null,"twitter_title":null,"twitter_description":null,"schema":{"blockGraphs":[],"customGraphs":[],"default":{"data":{"Article":[],"Course":[],"Dataset":[],"FAQPage":[],"Movie":[],"Person":[],"Product":[],"ProductReview":[],"Car":[],"Recipe":[],"Service":[],"SoftwareApplication":[],"WebPage":[]},"graphName":"WebPage","isEnabled":true},"graphs":[]},"schema_type":"default","schema_type_options":null,"pillar_content":false,"robots_default":true,"robots_noindex":false,"robots_noarchive":false,"robots_nosnippet":false,"robots_nofollow":false,"robots_noimageindex":false,"robots_noodp":false,"robots_notranslate":false,"robots_max_snippet":"-1","robots_max_videopreview":"-1","robots_max_imagepreview":"large","priority":null,"frequency":"default","local_seo":null,"limit_modified_date":false,"open_ai":"{\"title\":{\"suggestions\":[],\"usage\":0},\"description\":{\"suggestions\":[],\"usage\":0}}","created":"2025-12-05 00:39:34","updated":"2026-08-21 20:27:36","focus_keyword":null,"additional_keywords":null,"truseo_locale":null,"ai":{"faqs":[],"keyPoints":[],"schemas":[],"titles":[],"descriptions":[],"socialPosts":{"email":{"subject":"","preview":"","content":""},"linkedin":[],"twitter":[],"facebook":[],"instagram":[]}},"breadcrumb_settings":null,"seo_analyzer_scan_date":"2026-08-21 20:27:36"},"aioseo_breadcrumb":"<div class=\"aioseo-breadcrumbs\"><span class=\"aioseo-breadcrumb\">\n\t<a href=\"https:\/\/www.veeva.com\/eu\" title=\"Home\">Home<\/a>\n<\/span><span class=\"aioseo-breadcrumb-separator\">&raquo;<\/span><span class=\"aioseo-breadcrumb\">\n\t<a href=\"https:\/\/www.veeva.com\/eu\/customer-stories\/\" title=\"C. Stories\">C. Stories<\/a>\n<\/span><span class=\"aioseo-breadcrumb-separator\">&raquo;<\/span><span class=\"aioseo-breadcrumb\">\n\tDermavant\n<\/span><\/div>","aioseo_breadcrumb_json":[{"label":"Home","link":"https:\/\/www.veeva.com\/eu"},{"label":"C. Stories","link":"https:\/\/www.veeva.com\/eu\/customer-stories\/"},{"label":"Dermavant","link":"https:\/\/www.veeva.com\/eu\/customer-stories\/dermavant-sciences-shaves-weeks-off-its-nda-timeline\/"}],"_links":{"self":[{"href":"https:\/\/www.veeva.com\/eu\/wp-json\/wp\/v2\/customer-stories\/91387","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.veeva.com\/eu\/wp-json\/wp\/v2\/customer-stories"}],"about":[{"href":"https:\/\/www.veeva.com\/eu\/wp-json\/wp\/v2\/types\/customer-stories"}],"version-history":[{"count":1,"href":"https:\/\/www.veeva.com\/eu\/wp-json\/wp\/v2\/customer-stories\/91387\/revisions"}],"predecessor-version":[{"id":100103,"href":"https:\/\/www.veeva.com\/eu\/wp-json\/wp\/v2\/customer-stories\/91387\/revisions\/100103"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.veeva.com\/eu\/wp-json\/wp\/v2\/media\/62517"}],"wp:attachment":[{"href":"https:\/\/www.veeva.com\/eu\/wp-json\/wp\/v2\/media?parent=91387"}],"wp:term":[{"taxonomy":"product-link-list","embeddable":true,"href":"https:\/\/www.veeva.com\/eu\/wp-json\/wp\/v2\/product-link-list?post=91387"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}